Audacy’s Los Angeles news radio station KNX is ending its simulcast on 97.1 FM, which will move to a sports talk format on ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

KNX FM will switch from a news simulcast to an all-sports format with coverage of Southern California's college and pro sports landscape, station owners Audacy announced Tuesday. Stream Los Angeles ...

See more of our coverage in your search results. Add The New York Post on Google A beloved FM radio news station that boasted over 1 million listeners will be undergoing a drastic rebrand starting in ...

Bristol-Myers Squibb has said it will buy biotech MyoKardia in a $13.1 billion takeover that marks a step up in its development of cardiovascular drugs. The all-cash deal is mainly about MyoKardia’s ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as planned, even as star heart drug Camzyos faces new competition. A year ago, in the first quarter of 2025, BMS’ ...

Southern California radio gets its first-ever all-sports station on the FM band when 97.1 The Fan debuts on May 11, station owner Audacy announced on Tuesday. “Los Angeles is the epicenter of the ...

Preview this article 1 min New Jersey-based pharmaceutical manufacturer Bristol Myers Squibb is considering an investment of up to $1 billion for a plant in Houston. Here's why the company could be ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...